Scotts Miracle-Gro Q2 sales rise 5%, diluted EPS up 18%; fiscal 2026 guidance reaffirmed
Scotts Miracle-Gro reported second-quarter fiscal 2026 results for the three months ended March 28, 2026, with net sales of $1.46 billion, up 5%, and GAAP diluted earnings per share from continuing operations of $4.46, up 18%. The company reaffirmed its fiscal 2026 guidance, including non-GAAP adjusted EPS of $4.15 to $4.35, and said net leverage fell to 3.71x from 4.41x a year earlier. Shareholders should note that the Hawthorne business, now classified as discontinued, produced a $24.7 million quarterly loss and a $102.0 million six-month loss, which reduced six-month net income by 23%.
Key points
- Net sales were $1,459.5 million in the quarter versus $1,389.7 million a year earlier, up 5%.
- GAAP diluted EPS from continuing operations was $4.46 versus $3.78; non-GAAP adjusted diluted EPS was $4.53 versus $4.00, up 13%.
- Loss from discontinued operations (Hawthorne) was $24.7 million in the quarter and $102.0 million for six months; six-month net income was $113.6 million, down 23%.
- Fiscal 2026 guidance reaffirmed: non-GAAP adjusted EPS of $4.15 to $4.35 and free cash flow of $275 million; net leverage is expected to fall to the high 3s.
The filing
Written by AI on Nov 8, 2026, 1:01 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 29, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.